Overview
Pantoprazole in Cisplatin Nephrotoxicity
Status:
Recruiting
Recruiting
Trial end date:
2030-12-30
2030-12-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
Pantoprazole in Cisplatin NephrotoxicityPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Sherief Abd-ElsalamTreatments:
Cisplatin
Pantoprazole
Criteria
Inclusion Criteria:- Patients with head and neck cancer
Exclusion Criteria:
- GFR less than 59.
- DM
- Elevated liver enzymes more than 3 fold.